Download
Printer Friendly
Focused (
) Healthcare > Outsourced Biomedical Services > Drug Discovery Services > Lead Discovery/Validation/Optimization (^263315)
Industries & sectors
Products & services
Competitors
Customers
Suppliers
Partners
M&A scenario report
|
|||||||||||||||||||||||||||||
All Customers | As defined by the Company | Named as a supplier by other companies
| 7 Customer Found | ||||
| Displaying 1-7 |
Page of 1
|
|||
| Company | Ticker | Rel. Revenue (M) | Rel. Revenue % | Close Price | Hierarchy Focused Sector Path | Keywords |
|---|---|---|---|---|---|---|
| Roche Holding Ltd | RHHB Y | 12.0 | 44.37 | 37.77 | Healthcare > Biopharmaceuticals | Bicycle Therapeutics,Genentech,Bicycle peptides,immuno-oncology targets |
| Ionis Pharmaceuticals Inc | IONS | 10.7 | 39.79 | 37.91 | Healthcare > Biopharmaceuticals | Bicycle Therapeutics,Ionis Pharmaceuticals,Bicycle peptides,TFRC1,transferrin receptor,TfR1 Bicycles,oligonucleotide compounds |
| Novartis AG Basel | NVS | 1.9 | 7.08 | 113.95 | Healthcare > Biopharmaceuticals | Bicycle Therapeutics,Novartis |
| AstraZeneca Plc | AZN | 1.2 | 4.46 | 77.47 | Healthcare > Biopharmaceuticals | Bicycle Therapeutics,AstraZeneca,Bicycle peptides,lead optimization,peptide drug discovery platform |
| Bayer AG | BAYR Y | 1.2 | 4.30 | 8.22 | Healthcare | Bicycle Therapeutics,Bayer |
| Oxurion NV | n/a | n/a | 0.17 | Healthcare > Biopharmaceuticals > Ophthalmology > Degenerative Disorders | Bicycle Therapeutics,Oxurion,plasma kallikrein | |
| SV Health Investors LLP | n/a | n/a | Bicycle Therapeutics,Dementia Discovery Fund,Dementia |
Notes:
- Defined by the Company 
- Defined by Others